ClinVar Genomic variation as it relates to human health
NM_000518.5(HBB):c.*110_*111del
criteria provided, multiple submitters, no conflicts. Learn more about how ClinVar calculates review status.
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_000518.5(HBB):c.*110_*111del
Variation ID: 632843 Accession: VCV000632843.8
- Type and length
-
Deletion, 2 bp
- Location
-
Cytogenetic: 11p15.4 11: 5225487-5225488 (GRCh38) [ NCBI UCSC ] 11: 5246717-5246718 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Jun 3, 2019 Sep 16, 2024 Jun 21, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_000518.5:c.*110_*111del MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
3 prime UTR NM_000518.5:c.*110_*111delTA MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NM_000518.4:c.*110_*111del NC_000011.10:g.5225488_5225489del NC_000011.9:g.5246718_5246719del NG_000007.3:g.72128_72129del NG_046672.1:g.3423_3424del NG_053049.1:g.1809_1810del NG_059281.1:g.6584_6585del LRG_1232:g.6584_6585del LRG_1232t1:c.*110_*111del - Protein change
- -
- Other names
-
Poly(A) (-TA); (AATAAA>AAAA)
- Canonical SPDI
- NC_000011.10:5225486:TAT:T
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
HBB | - | - |
GRCh38 GRCh37 |
23 | 1896 | |
LOC107133510 | - | - | - | GRCh38 | - | 1843 |
LOC110006319 | - | - | - | GRCh38 | - | 1016 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Likely pathogenic (2) |
criteria provided, single submitter
|
Jun 21, 2024 | RCV000780307.4 | |
Pathogenic/Likely pathogenic (2) |
criteria provided, multiple submitters, no conflicts
|
Jul 28, 2022 | RCV002477785.4 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Likely pathogenic
(Jun 21, 2024)
C
Contributing to aggregate classification
|
criteria provided, single submitter
Method: clinical testing
|
beta Thalassemia
Affected status: unknown
Allele origin:
germline
|
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Accession: SCV000917474.2
First in ClinVar: Jun 03, 2019 Last updated: Sep 16, 2024 |
Comment:
Variant summary: HBB c.*110_*111delTA is located in the untranslated mRNA region downstream of the termination codon that lies in the 'known' polyA tail signal (AATAAA) … (more)
Variant summary: HBB c.*110_*111delTA is located in the untranslated mRNA region downstream of the termination codon that lies in the 'known' polyA tail signal (AATAAA) of HBB, and mutations in this region are known to reduce the synthesis of mRNA. Therefore, this variant is expected or likely to interfere with cleavage of transcript and addition of polyA tail, leading to an elongated transcript that is unstable (Orkin 1985). The variant allele was found at a frequency of 5.9e-06 in 1015192 control chromosomes (gnomAD database v4). c.*110_*111delTA has been reported twice in literature, one individual diagnosed with BTHAL and one individual having typical features of BTHAL minor (Ghanem_1992, Kimberland_1995). Ithanet lists variant as a "Globin gene causative mutation". In the same region, a variant c.*110T>C and c.*111A>G have been reported in literature as a common pathogenic variants. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 1301930, 21423179, 7599641). ClinVar contains an entry for this variant (Variation ID: 632843). Based on the evidence outlined above, the variant was classified as likely pathogenic. (less)
|
|
Pathogenic
(Jun 08, 2021)
C
Contributing to aggregate classification
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
unknown
|
Quest Diagnostics Nichols Institute San Juan Capistrano
Accession: SCV002774344.1
First in ClinVar: Dec 31, 2022 Last updated: Dec 31, 2022 |
Comment:
The variant disrupts the canonical polyadenylation signal, and is therefore predicted to result in the loss of a functional protein. The variant is found in … (more)
The variant disrupts the canonical polyadenylation signal, and is therefore predicted to result in the loss of a functional protein. The variant is found in at least one symptomatic individual, and not found in general population data. (less)
|
|
Likely pathogenic
(Jul 28, 2022)
C
Contributing to aggregate classification
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Accession: SCV003800237.2
First in ClinVar: Feb 13, 2023 Last updated: Mar 04, 2023 |
Comment:
The Poly A (-AT or -TA) variant (HBB: *110_*111delTA, rs63750205, HbVar ID: 972) is reported in an individual with beta-thalassemia and in an individual presenting … (more)
The Poly A (-AT or -TA) variant (HBB: *110_*111delTA, rs63750205, HbVar ID: 972) is reported in an individual with beta-thalassemia and in an individual presenting with typical beta-thalassemia trait (Ghanem 1992, HbVar link, Kimberland 1995). This variant is also listed in ClinVar (Variation ID: 632843), and in ITHANET as a causative variant (ITHANET link). It is absent from the Genome Aggregation Database, indicating it is not a common polymorphism. This variant is located in the untranslated mRNA region in the known polyA tail signal (AATAAA) of HBB. Other variants in this region (c.*110T>C, c.*111A>G) are common pathogenic variants shown to reduce mRNA synthesis (Orkin 1985). Based on available information, the *110_*111delTA variant is considered to be likely pathogenic. References: Link to HbVar database: https://globin.bx.psu.edu/hbvar/menu.html Link to ITHANET database: https://www.ithanet.eu/db/ithagenes?ithaID=277 Ghanem N et al. A comprehensive scanning method for rapid detection of beta-globin gene mutations and polymorphisms. Hum Mutat. 1992;1(3):229-39. PMID: 1301930. Kimberland ML, Boehm CD, Kazazian HH Jr. Two novel beta-thalassemia alleles: poly A signal (AATAAA-->AAAA) and -92 C-->T. Hum Mutat. 1995;5(3):275-6. PMID: 7599641. Orkin S et al. Thalassemia due to a mutation in the cleavage-polyadenylation signal of the human beta-globin gene. EMBO J. 1985; 4(2):453-6. PMID: 4018033. (less)
|
|
Pathogenic
(Nov 25, 2019)
N
Not contributing to aggregate classification
|
no assertion criteria provided
Method: curation
|
beta Thalassemia
Affected status: unknown
Allele origin:
germline
|
The ITHANET community portal, The Cyprus Institute of Neurology and Genetics
Accession: SCV001244460.1
First in ClinVar: May 04, 2020 Last updated: May 04, 2020 |
|
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Systematic documentation and analysis of human genetic variation in hemoglobinopathies using the microattribution approach. | Giardine B | Nature genetics | 2011 | PMID: 21423179 |
Two novel beta-thalassemia alleles: poly A signal (AATAAA-->AAAA) and -92 C-->T. | Kimberland ML | Human mutation | 1995 | PMID: 7599641 |
A comprehensive scanning method for rapid detection of beta-globin gene mutations and polymorphisms. | Ghanem N | Human mutation | 1992 | PMID: 1301930 |
https://ithanet.eu/db/ithagenes?ithaID=277 | - | - | - | - |
Text-mined citations for rs63750205 ...
HelpRecord last updated Jan 13, 2025
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.